Procoagulant activity of surface-immobilized Hageman factor

Biomaterials

Volumn 27, Issue 33, 2006, Pages 5643-5650

  Chatterjee, Kaushik ^a   Vogler, Erwin A ^b   Siedlecki, Christopher A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Blood compatibility; Coagulation; Plasma proteins

Indexed keywords

BLOOD COMPATIBILITY; PLASMA; PLASMA PROTEINS; PROCOAGULANT; PROTEIN-IMMOBILIZED MATERIAL;

BIOASSAY; BIOLOGICAL MATERIALS; BIOMATERIALS; COAGULATION; MATHEMATICAL MODELS; SOLUBILITY; SURFACE CHEMISTRY;

PROTEINS;

BLOOD CLOTTING FACTOR 12;

ARTICLE; BLOOD CLOTTING; BLOOD COMPATIBILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME IMMOBILIZATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOLUBILITY; SURFACE PROPERTY; WETTABILITY;

ADSORPTION; ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; CATTLE; COAGULANTS; ENZYMES, IMMOBILIZED; FACTOR XII; HUMANS; MATHEMATICS; MODELS, THEORETICAL; PLASMA; SERUM ALBUMIN, BOVINE; SURFACE PROPERTIES; WETTABILITY;

EID: 33747768295     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.07.025     Document Type: Article

References (37)

1. Lysaght M.J., and O'Loughlin J.A. Demographic scope and economic magnitude of contemporary organ replacement therapies. ASAIO J 46 (2000) 515-521
2. Ratner B.D. Blood compatibility-a perspective. J Biomater Sci: Polym ed 11 (2000) 1107-1119
3. McBride L.R., Naunheim K.S., Fiore A.C., Moroney D.A., and Swartz M.T. Clinical experience with 111 thoratec ventricular assist devices. Ann Thoracic Surg 67 (1999) 1233-1239
4. Galloway A.C., Anderson R.V., Grossi E.A., Spencer F.C., and Colvin S.B. Acquired heart diseases. In: Schwartz S.I. (Ed). Principles of Surgery. 7th ed (1999), McGraw Hill, New York 845-908
5. Andrade J.D., Coleman D.L., Didisheim P., Hanson S.R., Mason R., and Merrill E. Blood-materials interaction-20 years of frustation. Trans Am Soc Artif Intern Organs 27 (1981) 659-662
6. Ratner B.D. The blood compatibility catastrophe. J Biomed Mater Res 27 (1993) 283-287
7. Williams D.F. Blood physiology and biochemistry. In: Williams D.F. (Ed). Hemostasis and Thrombosis in Blood Compatibility (1987), CKC Press, Boca Raton, Florida 5-35
8. Colman R.W. Contact activation pathway: inflammatory, fibrinolytic, anticoagulant, antiadhesive, and antiangiogenic activities. In: George J.N. (Ed). Hemostasis and thrombosis-basic principles and clinical practice (2001), Lippincott William and William, Philadelphia 103-122
9. Revak S.D., Cochrane C.G., and Griffin J.H. The binding and cleavage characteristics of human Hageman factor during contact activation. J Clin Invest 59 (1977) 1167-1175
10. Ratnoff O.D., and Rosenblum J.M. Role of Hageman factor in the initiation of clotting by glass. Am J Med 25 (1958) 160-168
11. Kirby E.P., and McDevitt P.J. The binding of bovine factor XII to kaolin. Blood 61 (1983) 652-659
12. Vroman L. Effects of hydrophobic surfaces upon blood coagulation. Thromb Diath Haemorrhag 10 (1964) 455-493
13. Samuel M., Pixley R.A., Villanueva M.A., Colman R.W., and Villanueva G.B. Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies. J Biolog Chem 267 (1992) 19691-19697
14. Griffin J.H. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). Proc Natl Acad Sci USA 75 (1978) 1998-2002
15. Ratnoff O.D. The biology and pathology of the initial stages of blood coagulation. Progr Hematol 2 (1966) 204-245
16. Roach P., Farrar D., and Perry C.C. Interpretation of protein adsorption: surface-induced conformational changes. J Am Chem Soc 127 (2005) 8168-8173
17. Renner L., Pompe T., Salchert K., and Werner C. Fibronectin displacement at polymer surfaces. Langmuir 21 (2005) 4571-4577
18. Goncalves I.C., Martins M.C.L., Barbosa M.A., and Ratner B.D. Protein adsorption on 18-alkyl chains immobilized on hydroxyl-terminated self-assembled monolayers. Biomaterials 26 (2005) 3891-3899
19. Wu Y., Simonovsky F.I., Ratner B.D., and Horbett T.A. The role of adsorbed fibrinogen in platelet adhesion to polyurethane surfaces: a comparison of surface hydrophobicity, protein adsorption, monoclonal antibody binding, and platelet adhesion. J Biomed Mater Res Part A 74A (2005) 722-738
20. Sethuraman A., Han M., Kane R.S., and Belfort G. Effect of surface wettability on the adhesion of proteins. Langmuir 20 (2004) 7779-7788
21. Horbett T.A. Principles underlying the role of adsorbed plasma proteins in blood interactions with foreign materials. Cardiovasc Pathol 2 (1993) 137S-148S
22. Davie E.W., Fujikawa K., Kurachi K., and Kisiel W. The role of serine proteases in the blood coagulation cascade. Adv Enzymol Relat Areas Mol Biol 48 (1979) 277-318
23. Kaplan A.P. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, Hageman factor, prekallikrein, high molecular weight kininogen, and factor XI. Progr Hemost Thromb 4 (1978) 127-175
24. Griffin J.H., and Cochrane C.G. Recent advances in the understanding of contact activation reactions. Sem Thromb Hemost 5 (1979) 254-273
25. Meier H.L., Pierce J.V., Colman R.W., and Kaplan A.P. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest 60 (1977) 18-31
26. Wiggins R.C., Bouma B.N., Cochrane C.G., and Griffin J.H. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation factor XI and prekallikrein. Proc Natl Acad Sci USA 74 (1977) 4636-4640
27. Wiggins R.C. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein. J Biolog Chem 258 (1983) 8963-8970
28. Griffin J.H., and Cochrane C.G. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proc Natl Acad Sci USA 73 (1976) 2554-2558
29. Scott C.F., Silver L.D., Schapira M., and Colman R.W. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. J Clin Invest 73 (1984) 954-962
30. Guo Z., Bussard K.M., Chatterjee K., Miller R., Vogler E.A., and Siedlecki C.A. Mathematical modeling of material-induced blood plasma coagulation. Biomaterials 27 (2006) 796-806
31. Zhuo R., Miller R., Bussard K.M., Siedlecki C.A., and Vogler E.A. Procoagulant stimulus processing by the intrinsic pathway of blood plasma coagulation. Biomaterials 26 (2005) 2965-2973
32. Hermanson G.T., Mallia A.K., and Smith P. Immobilized affinity ligand techniques (1992), Academic Press, New York
33. Jones L.J., Haugland R.P., and Singer V.L. Development and characterization of the NanoOrange (R) protein quantitation assay: a fluorescence-based assay of proteins in solution. Biotechniques 34 (2003) 850-861
34. Vogler E.A., Graper J.C., Harper G.R., Sugg H.W., Lander L.M., and Brittain W.J. Contact activation of the plasma coagulation cascade I. Procoagulant surface chemistry and energy. J Biomed Mater Res 29 (1995) 1005-1016
35. Zhuo R., Siedlecki C.A., and Vogler E.A. Autoactivation of blood factor XII at hydrophilic and hydrophobic surfaces. Biomaterials 27 (2006) 4325-4332
36. Wagner M.S., Shen M., Horbett T.A., and Castner D.G. Quantitative analysis of binary adsorbed protein films by time of flight secondary ion mass spectrometry. J Biomed Mater Res Part A 64A (2003) 1-11
37. Teller D.C. Accessible area, packing volumes and interaction surfaces of globular proteins. Nature 260 (1976) 729-731